Beyond the Barriers of Light Penetration: Strategies, Perspectives and Possibilities for Photodynamic Therapy
暂无分享,去创建一个
Tayyaba Hasan | Sriram Anbil | Srivalleesha Mallidi | Girgis Obaid | T. Hasan | S. Mallidi | Sriram Anbil | G. Obaid | Anne-Laure Bulin | Anne-Laure Bulin | Megumi Ichikawa | Megumi Ichikawa | S. Anbil | Anne‐Laure Bulin
[1] V. Fingar,et al. Vascular effects of photodynamic therapy. , 1996, Journal of clinical laser medicine & surgery.
[2] Mamta Khurana,et al. Simultaneous Two-photon Excitation of Photofrin in Relation to Photodynamic Therapy , 2006, Photochemistry and photobiology.
[3] D. Kessel,et al. Enhanced Efficacy of Photodynamic Therapy via a Sequential Targeting Protocol , 2014, Photochemistry and photobiology.
[4] G. Xu,et al. Gold nanorod enhanced two-photon excitation fluorescence of photosensitizers for two-photon imaging and photodynamic therapy. , 2014, ACS applied materials & interfaces.
[5] Tayyaba Hasan,et al. Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer. , 2010, Cancer research.
[6] Ying Gu,et al. Synthesis and in vitro photocytotoxicity of coumarin derivatives for one- and two-photon excited photodynamic therapy. , 2013, Journal of medicinal chemistry.
[7] D. Cramb,et al. Near‐Infrared Two‐Photon Excitation of Protoporphyrin IX: Photodynamics and Photoproduct Generation ¶ , 2000, Photochemistry and photobiology.
[8] Wei Chen,et al. Using nanoparticles to enable simultaneous radiation and photodynamic therapies for cancer treatment. , 2006, Journal of nanoscience and nanotechnology.
[9] A. Colasanti,et al. Combined effects of radiotherapy and photodynamic therapy on an in vitro human prostate model. , 2004, Acta biochimica Polonica.
[10] M. Calin,et al. Photodynamic therapy in oncology , 2006 .
[11] Michael R Hamblin,et al. Biodistribution of charged F(ab')2 photoimmunoconjugates in a xenograft model of ovarian cancer. , 1997, British Journal of Cancer.
[12] H. Barr,et al. Comparison of lasers for photodynamic therapy with a phthalocyanine photosensitizer , 1989, Lasers in Medical Science.
[13] John F. Callan,et al. Extending the tissue penetration capability of conventional photosensitisers: a carbon quantum dot-protoporphyrin IX conjugate for use in two-photon excited photodynamic therapy. , 2013, Chemical communications.
[14] Hisataka Kobayashi,et al. Cancer Cell-Selective In Vivo Near Infrared Photoimmunotherapy Targeting Specific Membrane Molecules , 2011, Nature Medicine.
[15] Alexander M Seifalian,et al. Quantum dots and their potential biomedical applications in photosensitization for photodynamic therapy. , 2009, Nanomedicine.
[16] S. Jacques. Optical properties of biological tissues: a review , 2013, Physics in medicine and biology.
[17] U. Schmidt-Erfurth,et al. Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. , 2000, Survey of ophthalmology.
[18] P. Vandenabeele,et al. DAMPs and PDT-mediated photo-oxidative stress: exploring the unknown , 2011, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[19] Tayyaba Hasan,et al. Pretreatment photosensitizer dosimetry reduces variation in tumor response. , 2006, International journal of radiation oncology, biology, physics.
[20] J E Moulder,et al. The role of photodynamic therapy in posterior fossa brain tumors. A preclinical study in a canine glioma model. , 1993, Journal of neurosurgery.
[21] H. Oppelaar,et al. Targeting of a hydrophilic photosensitizer by use of internalizing monoclonal antibodies: A new possibility for use in photodynamic therapy , 2000, International journal of cancer.
[22] Tayyaba Hasan,et al. Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugates , 2014, Proceedings of the National Academy of Sciences.
[23] T. Hasan,et al. The "Nano" World in Photodynamic Therapy. , 2014, Austin journal of nanomedicine & nanotechnology.
[24] Amirhossein Ahmadi,et al. The effects of combined treatment with ionizing radiation and indocyanine green-mediated photodynamic therapy on breast cancer cells. , 2012, Journal of photochemistry and photobiology. B, Biology.
[25] Yong Zhang,et al. Nanoparticles in photodynamic therapy: an emerging paradigm. , 2008, Advanced drug delivery reviews.
[26] P B Cerrito,et al. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. , 1992, Cancer research.
[27] Johan Axelsson,et al. Cerenkov emission induced by external beam radiation stimulates molecular fluorescence. , 2011, Medical physics.
[28] H J Sterenborg,et al. Photodynamic therapy with pulsed light sources: a theoretical analysis , 1996, Physics in medicine and biology.
[29] T. Hasan,et al. Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer , 2014, British Journal of Cancer.
[30] Hazel A. Collins,et al. Two-photon absorption and the design of two-photon dyes. , 2009, Angewandte Chemie.
[31] Stefan Andersson-Engels,et al. Clinical system for interstitial photodynamic therapy with combined on-line dosimetry measurements. , 2005, Applied optics.
[32] Cristina Kurachi,et al. In vitro and in vivo evaluation of the induced PDT response using a femtosecond laser , 2009, World Congress of the International Photodynamic Association.
[33] C. Heusser,et al. Immunophotodiagnosis of colon carcinomas in patients injected with fluoresceinated chimeric antibodies against carcinoembryonic antigen. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[34] Timothy Solberg,et al. X-ray excited ZnS:Cu,Co afterglow nanoparticles for photodynamic activation , 2014 .
[35] L. Lilge,et al. Implicit and explicit dosimetry in photodynamic therapy: a New paradigm , 1997, Lasers in Medical Science.
[36] M. Korbelik,et al. Acute phase response-associated systemic neutrophil mobilization in mice bearing tumors treated by photodynamic therapy. , 2006, International immunopharmacology.
[37] L. Zitvogel,et al. Decoding Cell Death Signals in Inflammation and Immunity , 2010, Cell.
[38] David Kessel,et al. Photodynamic therapy of cancer: An update , 2011, CA: a cancer journal for clinicians.
[39] Chin-Tu Chen,et al. Enhanced Plasmonic Resonance Energy Transfer in Mesoporous Silica-Encased Gold Nanorod for Two-Photon-Activated Photodynamic Therapy , 2014, Theranostics.
[40] Barbara W Henderson,et al. Photodynamic therapy: a means to enhanced drug delivery to tumors. , 2003, Cancer research.
[41] Mark Horn,et al. The Effect of Molecular Weight, PK, and Valency on Tumor Biodistribution and Efficacy of Antibody-Based Drugs. , 2013, Translational oncology.
[42] P. Choyke,et al. Photoimmunotherapy Targeting Prostate-Specific Membrane Antigen: Are Antibody Fragments as Effective as Antibodies? , 2015, The Journal of Nuclear Medicine.
[43] Michael R Hamblin,et al. Epidermal growth factor receptor-targeted immunophotodiagnosis and photoimmunotherapy of oral precancer in vivo. , 2001, Cancer research.
[44] J. Moan,et al. Radiosensitization of tumours by porphyrins. , 2006, Cancer letters.
[45] Michael R Hamblin,et al. Experimental photoimmunotherapy of hepatic metastases of colorectal cancer with a 17.1A chlorin(e6) immunoconjugate. , 2000, Cancer research.
[46] Sabrina Oliveira,et al. Nanobody-photosensitizer conjugates for targeted photodynamic therapy. , 2014, Nanomedicine : nanotechnology, biology, and medicine.
[47] T. Hasan,et al. Verteporfin‐based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines , 2011, Lasers in Surgery and Medicine.
[48] M W Berns,et al. Ability of specific monoclonal antibodies and conventional antisera conjugated to hematoporphyrin to label and kill selected cell lines subsequent to light activation. , 1985, Cancer research.
[49] M. Korbelik,et al. Nitric oxide production by tumour tissue: impact on the response to photodynamic therapy , 2000, British Journal of Cancer.
[50] V. Bykerk,et al. Etanercept in the treatment of rheumatoid arthritis , 2007, Therapeutics and clinical risk management.
[51] M. Teulade‐Fichou,et al. Synthesis and characterization of glycoconjugated porphyrin triphenylamine hybrids for targeted two-photon photodynamic therapy. , 2014, The Journal of organic chemistry.
[52] Mamta Khurana,et al. Quantitative In Vitro Demonstration of Two‐Photon Photodynamic Therapy Using Photofrin® and Visudyne® , 2007, Photochemistry and photobiology.
[53] T Nishisaka,et al. Comparison of phototoxicity mechanism between pulsed and continuous wave irradiation in photodynamic therapy. , 1999, Journal of photochemistry and photobiology. B, Biology.
[54] Tayyaba Hasan,et al. The role of photodynamic therapy in overcoming cancer drug resistance , 2015, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[55] Jonathan F. Lovell,et al. Chemophototherapy: An Emerging Treatment Option for Solid Tumors , 2016, Advanced science.
[56] Paola Taroni,et al. Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocyanines and laser light , 1994, Anti-cancer drugs.
[57] Patrizia Agostinis,et al. Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. , 2007, Biochimica et biophysica acta.
[58] P. Low,et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results , 2011, Nature Medicine.
[59] J. Moore,et al. In vivo Expression of the Collagen-Related Heat Shock Protein HSP47, Following Hyperthermia or Photodynamic Therapy , 2001, Lasers in Medical Science.
[60] T. Dougherty. Photodynamic therapy. , 1993, Photochemistry and photobiology.
[61] Michael R Hamblin,et al. Intraperitoneal photoimmunotherapy of ovarian carcinoma xenografts in nude mice using charged photoimmunoconjugates. , 2000, Gynecologic oncology.
[62] Samuel Achilefu,et al. Breaking the Depth Dependency of Phototherapy with Cerenkov Radiation and Low Radiance Responsive Nanophotosensitizers , 2015, Nature nanotechnology.
[63] Vanderlei Salvador Bagnato,et al. Necrosis response to photodynamic therapy using light pulses in the femtosecond regime , 2013, Lasers in Medical Science.
[64] Brian Pogue,et al. Photosensitizer fluorescence and singlet oxygen luminescence as dosimetric predictors of topical 5-aminolevulinic acid photodynamic therapy induced clinical erythema , 2014, Journal of biomedical optics.
[65] M L Yarmush,et al. Antibody-targeted photolysis: selective photodestruction of human T-cell leukemia cells using monoclonal antibody-chlorin e6 conjugates. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[66] Anhe Wang,et al. Bioluminescent microcapsules: applications in activating a photosensitizer. , 2013, Chemistry.
[67] Zhuang Liu,et al. Upconversion Nanoparticles for Photodynamic Therapy and Other Cancer Therapeutics , 2013, Theranostics.
[68] M. Berns,et al. Combination cytotoxic chemotherapy with cisplatin or doxorubicin and photodynamic therapy in murine tumors. , 1988, Journal of the National Cancer Institute.
[69] Michael R Hamblin,et al. Cationic photoimmunoconjugates between monoclonal antibodies and hematoporphyrin: selective photodestruction of ovarian cancer cells. , 1998, Applied optics.
[70] G. Singh,et al. Induction of Hsp60 by Photofrin-mediated photodynamic therapy. , 2001, Journal of photochemistry and photobiology. B, Biology.
[71] Paras N. Prasad,et al. Photosensitization of Singlet Oxygen via Two-Photon-Excited Fluorescence Resonance Energy Transfer in a Water-Soluble Dendrimer , 2005 .
[72] A. Mantovani,et al. IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. , 2003, Trends in immunology.
[73] C. Poh,et al. Photodynamic therapy: a review and its prospective role in the management of oral potentially malignant disorders. , 2012, Oral diseases.
[74] M. Bentley,et al. Photodynamic Therapy of Skin Cancers: Sensitizers, Clinical Studies and Future Directives , 2000, Pharmaceutical Research.
[75] Sung Yong Choi,et al. Bioluminescence-Activated Deep-Tissue Photodynamic Therapy of Cancer , 2015, Theranostics.
[76] Chih-Ching Wu,et al. Subcellular localization of Photofrin® determines the death phenotype of human epidermoid carcinoma A431 cells triggered by photodynamic therapy: When plasma membranes are the main targets , 2003, Journal of cellular physiology.
[77] J. Weinstein,et al. Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier. , 1992, Cancer research.
[78] B. Pogue,et al. Transient absorption changes in vivo during photodynamic therapy with pulsed-laser light , 1999, British Journal of Cancer.
[79] S. Mordon,et al. Assessment of the specificity of a new folate-targeted photosensitizer for peritoneal metastasis of epithelial ovarian cancer to enable intraperitoneal photodynamic therapy. A preclinical study. , 2016, Photodiagnosis and photodynamic therapy.
[80] J. Woodhams,et al. The role of oxygen monitoring during photodynamic therapy and its potential for treatment dosimetry , 2007, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[81] Bryan Q. Spring,et al. A photoactivable multi-inhibitor nanoliposome for tumour control and simultaneous inhibition of treatment escape pathways , 2015, Nature nanotechnology.
[82] Gary T. Wang,et al. Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer. , 1990, Science.
[83] J. Parrish,et al. Therapeutic Uses of Light , 1985, Annals of the New York Academy of Sciences.
[84] Barbara W Henderson,et al. Generation of effective antitumor vaccines using photodynamic therapy. , 2002, Cancer research.
[85] Ching-Wen Chen,et al. Bioluminescence resonance energy transfer using luciferase-immobilized quantum dots for self-illuminated photodynamic therapy. , 2013, Biomaterials.
[86] Erkinay Abliz,et al. Novel applications of diagnostic X-rays in activating a clinical photodynamic drug: Photofrin II through X-ray induced visible luminescence from "rare-earth" formulated particles. , 2011, Journal of X-ray science and technology.
[87] Antony K. Chen,et al. Efficient cytosolic delivery of molecular beacon conjugates and flow cytometric analysis of target RNA , 2008, Nucleic acids research.
[88] Feng Liu,et al. Nanoscintillator-mediated X-ray inducible photodynamic therapy for in vivo cancer treatment. , 2015, Nano letters.
[89] William R. Dichtel,et al. Singlet oxygen generation via two-photon excited FRET. , 2004, Journal of the American Chemical Society.
[90] K. Okkenhaug,et al. Firefly luciferin-activated rose bengal: in vitro photodynamic therapy by intracellular chemiluminescence in transgenic NIH 3T3 cells. , 2003, Cancer research.
[91] Smita Dayal,et al. Quantum Dot-based Energy Transfer: Perspectives and Potential for Applications in Photodynamic Therapy , 2006, Photochemistry and photobiology.
[92] H. Asanuma,et al. Differences between cytotoxicity in photodynamic therapy using a pulsed laser and a continuous wave laser: study of oxygen consumption and photobleaching , 2004, Lasers in Medical Science.
[93] Michael R Hamblin,et al. Photodynamic therapy and anti-tumour immunity , 2006, Nature Reviews Cancer.
[94] B. Lovisa,et al. Angiostatic kinase inhibitors to sustain photodynamic angio-occlusion , 2012, Journal of cellular and molecular medicine.
[95] Tayyaba Hasan,et al. Optical Imaging, Photodynamic Therapy and Optically Triggered Combination Treatments , 2015, Cancer journal.
[96] Sanjiv S Gambhir,et al. Self-illuminating quantum dot conjugates for in vivo imaging , 2006, Nature Biotechnology.
[97] David H. Kessel. Photodynamic Therapy: Back to the Future , 2009 .
[98] N. Lange,et al. Combination of photodynamic therapy with anti-cancer agents. , 2008, Current medicinal chemistry.
[99] D. Doiron,et al. Photodynamic Therapy for Nonmelanoma Skin Cancer , 1989, Facial plastic surgery : FPS.
[100] Stefan Andersson-Engels,et al. Photodynamic therapy: superficial and interstitial illumination. , 2010, Journal of biomedical optics.
[101] K. Nishio,et al. Antibody‐dependent cellular cytotoxicity of cetuximab against tumor cells with wild‐type or mutant epidermal growth factor receptor , 2007, Cancer science.
[102] Mladen Korbelik,et al. Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response. , 2005, Cancer research.
[103] A. Meyers,et al. PHOTODYNAMIC THERAPY — AN UPDATE ON CLINICAL APPLICATIONS , 2009 .
[104] Muriel Barberi-Heyob,et al. X-ray-Induced singlet oxygen activation with nanoscintillator-coupled porphyrins , 2013 .
[105] Mark D. Savellano,et al. Epidermal growth factor receptor-targeted photosensitizer selectively inhibits EGFR signaling and induces targeted phototoxicity in ovarian cancer cells. , 2012, Cancer letters.
[106] Michael R Hamblin,et al. Biodistribution of charged 17.1A photoimmunoconjugates in a murine model of hepatic metastasis of colorectal cancer , 2000, British Journal of Cancer.
[107] Stanley B. Brown,et al. The present and future role of photodynamic therapy in cancer treatment. , 2004, The Lancet. Oncology.
[108] Daniel Rohrbach,et al. Monitoring photobleaching and hemodynamic responses to HPPH-mediated photodynamic therapy of head and neck cancer: a case report. , 2010, Optics express.
[109] S. Mennel,et al. Ocular Photodynamic Therapy – Standard Applications and New Indications (Part 1) , 2007, Ophthalmologica.
[110] G. Xu,et al. Gold nanorods as dual photo-sensitizing and imaging agents for two-photon photodynamic therapy. , 2012, Nanoscale.
[111] T. Hasan,et al. Photoimmunotherapy of human ovarian carcinoma cells ex vivo. , 1991, Cancer research.
[112] H. S. de Bruijn,et al. EGFR targeted nanobody–photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[113] J. Bhawalkar,et al. Two-photon photodynamic therapy. , 1997, Journal of clinical laser medicine & surgery.
[114] K. Camphausen,et al. Nanoscintillator Conjugates as Photodynamic Therapy-Based Radiosensitizers: Calculation of Required Physical Parameters , 2009, Radiation research.
[115] Michael R Hamblin,et al. Cell Death Pathways in Photodynamic Therapy of Cancer , 2011, Cancers.
[116] Britton Chance,et al. Protease-triggered photosensitizing beacon based on singlet oxygen quenching and activation. , 2004, Journal of the American Chemical Society.
[117] Lothar Lilge,et al. Metronomic Photodynamic Therapy as a New Paradigm for Photodynamic Therapy: Rationale and Preclinical Evaluation of Technical Feasibility for Treating Malignant Brain Tumors¶ , 2004, Photochemistry and photobiology.
[118] Ulysses W. Sallum,et al. Exploiting a bacterial drug-resistance mechanism: a light-activated construct for the destruction of MRSA. , 2009, Angewandte Chemie.
[119] H. C. de Vijlder,et al. Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial. , 2012, Acta dermato-venereologica.
[120] Tayyaba Hasan,et al. Photodynamic Therapy Synergizes with Irinotecan to Overcome Compensatory Mechanisms and Improve Treatment Outcomes in Pancreatic Cancer. , 2016, Cancer research.
[121] J. Borrell,et al. Two-photon absorption in tetraphenylporphycenes: are porphycenes better candidates than porphyrins for providing optimal optical properties for two-photon photodynamic therapy? , 2007, Journal of the American Chemical Society.
[122] Chunlei Zhu,et al. Chemical molecule-induced light-activated system for anticancer and antifungal activities. , 2012, Journal of the American Chemical Society.
[123] R. Supino,et al. On the combination of photodynamic therapy with ionizing radiation. , 1999, Journal of photochemistry and photobiology. B, Biology.
[124] Gang Zheng,et al. Activatable photosensitizers for imaging and therapy. , 2010, Chemical reviews.
[125] Patrizio Salice,et al. Assessment of water-soluble pi-extended squaraines as one- and two-photon singlet oxygen photosensitizers: design, synthesis, and characterization. , 2008, Journal of the American Chemical Society.
[126] M. Korbelik,et al. Role of Complement Anaphylatoxin C3a in Photodynamic Therapy-elicited Engagement of Host Neutrophils and Other Immune Cells , 2006, Photochemistry and photobiology.
[127] A. Oseroff,et al. Photodynamic therapy for nonmelanoma skin cancers. Current review and update. , 2003, Molecular immunology.
[128] Shannon M. Gallagher-Colombo,et al. Erlotinib Pretreatment Improves Photodynamic Therapy of Non-Small Cell Lung Carcinoma Xenografts via Multiple Mechanisms. , 2015, Cancer research.
[129] B. Wilson,et al. Matrix metalloproteinase-based photodynamic molecular beacons for targeted destruction of bone metastases in vivo , 2016, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[130] S. Mennel,et al. Ocular Photodynamic Therapy – Standard Applications and New Indications (Part 2) , 2007, Ophthalmologica.
[131] Matthieu Réfrégiers,et al. X-ray-induced radiophotodynamic therapy (RPDT) using lanthanide micelles: Beyond depth limitations , 2015, Nano Research.
[132] H. S. de Bruijn,et al. Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo. , 1996, Cancer research.
[133] S. Bradforth,et al. Photoluminescence of cerium fluoride and cerium-doped lanthanum fluoride nanoparticles and investigation of energy transfer to photosensitizer molecules. , 2014, Physical chemistry chemical physics : PCCP.
[134] B. Wilson,et al. Photodynamic molecular beacon as an activatable photosensitizer based on protease-controlled singlet oxygen quenching and activation , 2007, Proceedings of the National Academy of Sciences.
[135] Brian W. Pogue,et al. Fluorescent Affibody Peptide Penetration in Glioma Margin Is Superior to Full Antibody , 2013, PloS one.
[136] J. E. Rogers,et al. Light-Harvesting Chromophores with Metalated Porphyrin Cores for Tuned Photosensitization of Singlet Oxygen via Two-Photon Excited FRET , 2006 .
[137] PhD Meike L. Schipper MD,et al. Evaluation of Firefly Luciferase Bioluminescence Mediated Photodynamic Toxicity in Cancer Cells , 2006, Molecular Imaging and Biology.
[138] Tayyaba Hasan,et al. Prediction of Tumor Recurrence and Therapy Monitoring Using Ultrasound-Guided Photoacoustic Imaging , 2015, Theranostics.
[139] J. Nicoud,et al. Diketopyrrolopyrrole-porphyrin conjugates with high two-photon absorption and singlet oxygen generation for two-photon photodynamic therapy. , 2015, Angewandte Chemie.
[140] W. Morgan,et al. Non-targeted and Delayed Effects of Exposure to Ionizing Radiation: II. Radiation-Induced Genomic Instability and Bystander Effects In Vivo, Clastogenic Factors and Transgenerational Effects , 2003, Radiation research.
[141] J Moan,et al. Combined treatment of ionizing radiation and photosensitization by 5-aminolevulinic acid-induced protoporphyrin IX. , 1995, Radiation Research.
[142] S. Mordon,et al. Continuous or fractionated photodynamic therapy? Comparison of three PDT schemes for ovarian peritoneal micrometastasis treatment in a rat model. , 2010, Photodiagnosis and photodynamic therapy.
[143] Tayyaba Hasan,et al. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. , 2010, Chemical reviews.
[144] Paras N Prasad,et al. Organically modified silica nanoparticles co-encapsulating photosensitizing drug and aggregation-enhanced two-photon absorbing fluorescent dye aggregates for two-photon photodynamic therapy. , 2007, Journal of the American Chemical Society.
[145] M S Patterson,et al. Absorbed photodynamic dose from pulsed versus continuous wave light examined with tissue-simulating dosimeters. , 1997, Applied optics.
[146] Paul M. Ripley,et al. Photodynamic therapy for cancer of the pancreas , 2002, Gut.
[147] Michael R Hamblin,et al. Photodynamic Therapy for Cancer and for Infections: What Is the Difference? , 2012, Israel journal of chemistry.
[148] Dalong Ni,et al. Marriage of scintillator and semiconductor for synchronous radiotherapy and deep photodynamic therapy with diminished oxygen dependence. , 2015, Angewandte Chemie.
[149] H. S. de Bruijn,et al. Increase in protoporphyrin IX after 5-aminolevulinic acid based photodynamic therapy is due to local re-synthesis , 2007, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[150] T. Hasan,et al. Photoimmunotherapy and biodistribution with an OC125-chlorin immunoconjugate in an in vivo murine ovarian cancer model. , 1994, British Journal of Cancer.
[151] A. Joly,et al. Investigation of water-soluble x-ray luminescence nanoparticles for photodynamic activation , 2008 .
[152] R. Allison. Photodynamic therapy: oncologic horizons. , 2014, Future oncology.
[153] Mikhail Drobizhev,et al. Synthesis, characterization and two-photon PDT efficacy studies of triads incorporating tumor targeting and imaging components , 2008, SPIE BiOS.
[154] A. Melcher,et al. Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake. , 1999, Journal of immunology.
[155] Petras Juzenas,et al. Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. , 2008, Advanced drug delivery reviews.
[156] B. Wilson,et al. Facile synthesis of advanced photodynamic molecular beacon architectures. , 2010, Bioconjugate chemistry.
[157] Christophe Dujardin,et al. Modelling energy deposition in nanoscintillators to predict the efficiency of the X-ray-induced photodynamic effect. , 2015, Nanoscale.
[158] L. Zitvogel,et al. Molecular characteristics of immunogenic cancer cell death , 2008, Cell Death and Differentiation.
[159] A. Schauer,et al. Pulsed versus continuous wave excitation mechanisms in photodynamic therapy of differently graded squamous cell carcinomas in tumor-implanted nude mice , 2004, European Archives of Oto-Rhino-Laryngology.
[160] B. Pogue,et al. Vascular and cellular targeting for photodynamic therapy. , 2006, Critical reviews in eukaryotic gene expression.
[161] Chin‐Hung Lai,et al. A New Series of Quadrupolar Type Two‐Photon Absorption Chromophores Bearing 11, 12‐Dibutoxydibenzo[a,c]‐phenazine Bridged Amines; Their Applications in Two‐Photon Fluorescence Imaging and Two‐Photon Photodynamic Therapy , 2009 .
[162] Joshua S Richman,et al. Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer , 2015, Clinical Cancer Research.
[163] T. Hasan,et al. Benzophenothiazine and Benzoporphyrin Derivative Combination Phototherapy Effectively Eradicates Large Murine Sarcomas , 1996, Photochemistry and photobiology.
[164] P. Agostinis,et al. ER stress, autophagy and immunogenic cell death in photodynamic therapy-induced anti-cancer immune responses , 2014, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[165] Michael R Hamblin,et al. A green fluorescent protein-expressing murine tumour but not its wild-type counterpart is cured by photodynamic therapy , 2006, British Journal of Cancer.
[166] B W Henderson,et al. Role of cytokines in photodynamic therapy-induced local and systemic inflammation , 2003, British Journal of Cancer.
[167] B. Wilson,et al. Complete blood vessel occlusion in the chick chorioallantoic membrane using two-photon excitation photodynamic therapy: implications for treatment of wet age-related macular degeneration. , 2007, Journal of biomedical optics.
[168] M S Patterson,et al. The physics of photodynamic therapy. , 1986, Physics in medicine and biology.
[169] J. Krosl,et al. Potentiation of photodynamic therapy-elicited antitumor response by localized treatment with granulocyte-macrophage colony-stimulating factor. , 1996, Cancer research.
[170] W. Denk,et al. Two-photon laser scanning fluorescence microscopy. , 1990, Science.
[171] B. Pogue,et al. PDT Dose Parameters Impact Tumoricidal Durability and Cell Death Pathways in a 3D Ovarian Cancer Model , 2013, Photochemistry and photobiology.
[172] Atsushi Ohashi,et al. Strong two-photon absorption of self-assembled butadiyne-linked bisporphyrin. , 2004, Journal of the American Chemical Society.
[173] Dominik J Naczynski,et al. Rare Earth Nanoprobes for Functional Biomolecular Imaging and Theranostics. , 2014, Journal of materials chemistry. B.
[174] Ying-xin Li,et al. Generation of effective vaccines against liver cancer by using photodynamic therapy , 2009, Lasers in Medical Science.
[175] M. Peev,et al. Photodynamic therapy of experimental tumours with Zn(II)-phthalocyanine and pulsed laser irradiation , 1995, Lasers in Medical Science.
[176] S. Jacques. How tissue optics affect dosimetry of photodynamic therapy. , 2010, Journal of biomedical optics.
[177] P Lenz,et al. In vivo EXCITATION OF PHOTOSENSITIZERS BY INFRARED LIGHT , 1995, Photochemistry and photobiology.
[178] L. Le Bodic,et al. Neodymium-yttrium aluminium garnet laser destruction of nonsensitized and hematoporphyrin derivative-sensitized tumors. , 1983, Cancer research.
[179] S. Carpenter,et al. Chemiluminescent activation of the antiviral activity of hypericin: a molecular flashlight. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[180] V. Jarý,et al. Preliminary study on singlet oxygen production using CeF3:Tb3+@SiO2-PpIX , 2016 .
[181] Michael R Hamblin,et al. Pegylation of charged polymer-photosensitiser conjugates: effects on photodynamic efficacy , 2003, British Journal of Cancer.
[182] W. Jerjes,et al. Prospective evaluation of 110 patients following ultrasound-guided photodynamic therapy for deep seated pathologies. , 2011, Photodiagnosis and photodynamic therapy.
[183] C J Gomer,et al. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. , 2000, Cancer research.
[184] S. Gollnick. Photodynamic therapy and antitumor immunity. , 2012, Journal of the National Comprehensive Cancer Network : JNCCN.
[185] Mark D. Savellano,et al. Photochemical Targeting of Epidermal Growth Factor Receptor: A Mechanistic Study , 2005, Clinical Cancer Research.
[186] S. Gollnick,et al. Peroxiredoxin 1 Stimulates Secretion of Proinflammatory Cytokines by Binding to TLR4 , 2009, The Journal of Immunology.
[187] Yuriy Stepanenko,et al. Extremely strong near-IR two-photon absorption in conjugated porphyrin dimers: quantitative description with three-essential-states model. , 2005, The journal of physical chemistry. B.
[188] Bryan Q. Spring,et al. Simultaneous delivery of cytotoxic and biologic therapeutics using nanophotoactivatable liposomes enhances treatment efficacy in a mouse model of pancreatic cancer. , 2016, Nanomedicine : nanotechnology, biology, and medicine.
[189] J. Levy,et al. Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates. , 1983, Journal of immunology.
[190] Ahmed H. Elmenoufy,et al. Nanocomposite-Based Photodynamic Therapy Strategies for Deep Tumor Treatment. , 2015, Small.
[191] Tayyaba Hasan,et al. Revisiting photodynamic therapy dosimetry: reductionist & surrogate approaches to facilitate clinical success , 2016, Physics in medicine and biology.
[192] P. Ogilby,et al. Two-photon photosensitized production of singlet oxygen. , 2001, Journal of the American Chemical Society.
[193] K. Soo,et al. Nanoparticles in photodynamic therapy. , 2015, Chemical reviews.
[194] Aleksander Rebane,et al. Blood-vessel closure using photosensitizers engineered for two-photon excitation , 2008 .
[195] Mark D. Savellano,et al. Targeting Cells That Overexpress the Epidermal Growth Factor Receptor with Polyethylene Glycolated BPD Verteporfin Photosensitizer Immunoconjugates¶ , 2003, Photochemistry and photobiology.
[196] Tayyaba Hasan,et al. Development and applications of photo-triggered theranostic agents. , 2010, Advanced drug delivery reviews.